Clinicopathological characteristics and diagnostic performance of Wisteria floribunda agglutinin positive Mac-2-binding protein as a preoperative serum marker of liver fibrosis in hepatocellular carcinoma

[1]  Y. Imai,et al.  Association between Wisteria floribunda agglutinin-positive Mac-2 binding protein and the fibrosis stage of non-alcoholic fatty liver disease , 2015, Journal of Gastroenterology.

[2]  A. Kuno,et al.  Elevated serum levels of Wisteria floribunda agglutinin-positive human Mac-2 binding protein predict the development of hepatocellular carcinoma in hepatitis C patients , 2014, Hepatology.

[3]  A. Kuno,et al.  Application of a glycoproteomics-based biomarker development method: alteration in glycan structure on colony stimulating factor 1 receptor as a possible glycobiomarker candidate for evaluation of liver cirrhosis. , 2014, Journal of proteome research.

[4]  Y. Maehara,et al.  A novel serum marker, glycosylated Wisteria floribunda agglutinin-positive Mac-2 binding protein (WFA+-M2BP), for assessing liver fibrosis , 2014, Journal of Gastroenterology.

[5]  Motofumi Tanaka,et al.  Assessment of ISGLS Definition of Posthepatectomy Liver Failure and Its Effect on Outcome in Patients with Hepatocellular Carcinoma , 2014, Journal of Gastrointestinal Surgery.

[6]  A. Kuno,et al.  Reconstruction of a robust glycodiagnostic agent supported by multiple lectin‐assisted glycan profiling , 2013, Proteomics. Clinical applications.

[7]  Masakazu Yamamoto,et al.  Glycoproteomics-based cancer marker discovery adopting dual enrichment with Wisteria floribunda agglutinin for high specific glyco-diagnosis of cholangiocarcinoma. , 2013, Journal of proteomics.

[8]  A. Kuno,et al.  A serum “sweet-doughnut” protein facilitates fibrosis evaluation and therapy assessment in patients with viral hepatitis , 2013, Scientific Reports.

[9]  S. Todo,et al.  Analysis of the risk factors for early death due to disease recurrence or progression within 1 year after hepatectomy in patients with hepatocellular carcinoma , 2012, World Journal of Surgical Oncology.

[10]  Laurent Castera,et al.  Noninvasive methods to assess liver disease in patients with hepatitis B or C. , 2012, Gastroenterology.

[11]  Julien Vergniol,et al.  Noninvasive tests for fibrosis and liver stiffness predict 5-year outcomes of patients with chronic hepatitis C. , 2011, Gastroenterology.

[12]  Y. Maehara,et al.  New method for assessing liver fibrosis based on acoustic radiation force impulse: a special reference to the difference between right and left liver , 2011, Journal of Gastroenterology.

[13]  S. Todo,et al.  Perioperative management of hepatic resection toward zero mortality and morbidity: analysis of 793 consecutive cases in a single institution. , 2010, Journal of the American College of Surgeons.

[14]  Masakazu Yamamoto,et al.  Wisteria floribunda agglutinin‐positive mucin 1 is a sensitive biliary marker for human cholangiocarcinoma , 2010, Hepatology.

[15]  W. A. Mardin,et al.  Prognostic Impact of Underlying Liver Fibrosis and Cirrhosis After Curative Resection of Hepatocellular Carcinoma , 2010, World Journal of Surgery.

[16]  I. Colle,et al.  The HCV serum proteome: a search for fibrosis protein markers , 2009, Journal of viral hepatitis.

[17]  Y. Maehara,et al.  Trends in morbidity and mortality after hepatic resection for hepatocellular carcinoma: an institute's experience with 625 patients. , 2007, Journal of the American College of Surgeons.

[18]  J. Montaner,et al.  Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection , 2006, Hepatology.

[19]  Y. Nakajima,et al.  Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma , 2002, The British journal of surgery.

[20]  P Bork,et al.  Domain organization of Mac-2 binding protein and its oligomerization to linear and ring-like structures. , 1999, Journal of molecular biology.

[21]  R. Timpl,et al.  Mac‐2 binding protein is a cell‐adhesive protein of the extracellular matrix which self‐assembles into ring‐like structures and binds β1 integrins, collagens and fibronectin , 1998, The EMBO journal.

[22]  Takao Tsuji,et al.  New Inuyama classification; new criteria for histological assessment of chronic hepatitis , 1996 .

[23]  N. Tinari,et al.  Elevated serum levels of 90K/MAC-2 BP predict unresponsiveness to alpha-interferon therapy in chronic HCV hepatitis patients. , 1996, Journal of hepatology.

[24]  A. Ullrich,et al.  The secreted tumor-associated antigen 90K is a potent immune stimulator. , 1994, The Journal of biological chemistry.

[25]  E. Taylor,et al.  Cloning and characterization of a human Mac-2-binding protein, a new member of the superfamily defined by the macrophage scavenger receptor cysteine-rich domain. , 1993, The Journal of biological chemistry.

[26]  T. Springer,et al.  Mac-2, a novel 32,000 Mr mouse macrophage subpopulation-specific antigen defined by monoclonal antibodies. , 1982, Journal of immunology.